Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Graft Polymer (UK) PLC (GB:GPL)
LSE:GPL
RESEARCH TOOLSreports
Holding GB:GPL?
Track your performance easily
GPL Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range0.10p - 1.41p
Previous Close0.22p
Volume7.88M
Average Volume (3M)34.48M
Market Cap
£4.94M
Enterprise Value3.32M
Total Cash (Recent Filing)£1.64M
Total Debt (Recent Filing)£22.00K
Price to Earnings (P/E)―
Beta-1.00
Next Earnings
Jun 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding2,295,930,633
10 Day Avg. Volume27,393,685
30 Day Avg. Volume34,483,025
Standard Deviation1.11
R-Squared0.00270
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)10.55
Price to Cash Flow (P/CF)-2.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Graft Polymer (UK) PLC News
PremiumCompany Announcements
Graft Polymer to Acquire Awakn Life Sciences for Strategic Expansion
PremiumCompany Announcements
Graft Polymer’s Promising Pre-Clinical Results in PTSD Treatment Programme
PremiumCompany Announcements
Graft Polymer Rebrands Amid Strategic Shift and Collaboration
PremiumCompany Announcements
Graft Polymer Advances PTSD Therapeutic Research
PremiumCompany Announcements
Graft Polymer Advances PTSD Treatment ResearchPremiumCompany Announcements
Graft Polymer Welcomes New Chairman
PremiumCompany Announcements
Graft Polymer Appoints Biotech Veteran as ChairmanOptions Prices
Currently, No data available
---
Ownership Overview
GPL FAQ
What was Graft Polymer (UK) PLC’s price range in the past 12 months?
Graft Polymer (UK) PLC lowest share price was 0.10p and its highest was 1.41p in the past 12 months.
What is Graft Polymer (UK) PLC’s market cap?
Currently, no data Available
When is Graft Polymer (UK) PLC’s upcoming earnings report date?
Graft Polymer (UK) PLC’s upcoming earnings report date is Jun 25, 2025 which is in 184 days.
How were Graft Polymer (UK) PLC’s earnings last quarter?
Graft Polymer (UK) PLC released its earnings results on Sep 13, 2024. The company reported -0.005p earnings per share for the quarter, missing the consensus estimate of N/A by -0.005p.
Is Graft Polymer (UK) PLC overvalued?
According to Wall Street analysts Graft Polymer (UK) PLC’s price is currently Overvalued.
Does Graft Polymer (UK) PLC pay dividends?
Graft Polymer (UK) PLC does not currently pay dividends.
What is Graft Polymer (UK) PLC’s EPS estimate?
Graft Polymer (UK) PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Graft Polymer (UK) PLC have?
Graft Polymer (UK) PLC has 2,295,930,700 shares outstanding.
What happened to Graft Polymer (UK) PLC’s price movement after its last earnings report?
Graft Polymer (UK) PLC reported an EPS of -0.005p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Graft Polymer (UK) PLC?
Currently, no hedge funds are holding shares in GB:GPL
---
Graft Polymer (UK) PLC Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-78.50%
12-Months-Change
Fundamentals
Return on Equity
-96.19%
Trailing 12-Months
Asset Growth
-42.27%
Trailing 12-Months
Company Description
Graft Polymer (UK) PLC
Graft Polymer (UK) PLC focuses on the development of polymer modification and drug delivery systems. It has licensed its Drug Delivery System platform IP to MGC Pharmaceuticals in relation to MGC Pharma's CimetrA product. The group's products address customer needs across a wide range of end use markets, from automotive through to medical and are not dependent on one market segment.
---
Technical Analysis
---